Tenders Are Invited For Conclusion Of Non-Exclusive Discount Agreements According To Section 130 A Paragraph ...
Tender Notice
TenderID
70651788
Tender Brief
Tenders Are Invited For Conclusion Of Non-Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V For Medicines With The Active Ingredient Buserelin
Conclusion Of Non-Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V For Medicines With The Active Ingredient Buserelin. Section 130A Paragraph 8 Sgb V Enables Health Insurance Companies (Kk) And Pharmaceutical Companies To Conclude Framework Discount Agreements For The Medicines To Be Supplied At The Expense Of The Statutory Kk. Gwq Acts As A Company For Efficiency And Quality At Kk In Accordance With Section 130A Paragraph 8 Sentence 5 Sgbv For Its Shareholders And Customer Funds. With Regard To The Relevant Legal Regulations For The Awarding Of Public Contracts, A Regular Process Of Active Ingredient-Related, Formal Procurement Procedures Takes Place In Accordance With The Regulations Of Part 4 Of The Gwb By Gwq Serviceplus Ag. Until New Drug Discount Agreements Come Into Force, Gwq Would Like To Conclude Drug Discount Agreements With All Interested Pharmaceutical Companies. The Contract Starts On November 1St, 2023
Dear Sir,
Warm Greetings from TenderDetail.com !!
We have received Tender Document request for the TDR No : 70651788
Tender Notice along with it's Attachments ( Tender Document / Scan Image of News Paper)
sent to your Email Address :.
Please check your email for Tender Document.
